Latest Pharmasset News
Nov 8, 2021
A new, prominent Board of Directors The new round of funding adds several notable names to bit.bio’s board of directors, including monoclonal antibody innovator and Nobel-winning scientist Greg Winter, Amadeus Capital Partners co-founder Dr. Hermann Hauser, and Pharmasset and Roivant founder Alan S. Roemer. Please leave this field empty Want to stay on top of the latest rounds, coolest tech and hottest startups? Subscribe to our free, daily news blast and stay up-to-date! Check your inbox or spam folder to confirm your subscription.
Pharmasset has filed 8 patents.